insights_auto
Why is CHGCF up 2.22%?
Dive Deeperchevron_right
CHGCF:OTCMKTS
Chugai Pharmaceutical Co Ltd
$38.00
arrow_upward
+2.22%(+0.83) 1D
Oct 9, 12:22:08 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCF...
Open
$35.51
High
$39.29
Low
$35.51
Mkt. cap
10.11T
Avg. vol.
11.21K
Volume
6.34K
52-wk high
$68.08
52-wk low
$34.79
Beta
1.91
Shares outstanding
1.68B
No. of employees
5K
Open
$35.51
High
$39.29
Low
$35.51
Mkt. cap
10.11T
Avg. vol.
11.21K
Volume
6.34K
52-wk high
$68.08
52-wk low
$34.79
Beta
1.91
Shares outstanding
1.68B
No. of employees
5K
News stories
From web sources and news partners
AD HOC NEWS
·
3 hours ago
Chugai Pharmaceutical stock at EUR 33.98 with volume 9.4 percent above average
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp